| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.04B | 3.44B | 3.30B | 2.66B | 2.24B |
| Gross Profit | 1.21B | 1.71B | 1.72B | 1.39B | 1.04B |
| EBITDA | 712.08M | 1.11B | 1.27B | 1.01B | 752.93M |
| Net Income | 408.19M | 801.13M | 973.61M | 744.54M | 565.22M |
Balance Sheet | |||||
| Total Assets | 6.52B | 6.78B | 6.73B | 6.16B | 5.24B |
| Cash, Cash Equivalents and Short-Term Investments | 1.50B | 1.52B | 2.09B | 2.01B | 2.21B |
| Total Debt | 6.50M | 10.45M | 17.58M | 27.01M | 31.19M |
| Total Liabilities | 2.81B | 2.84B | 2.60B | 2.29B | 1.87B |
| Stockholders Equity | 3.62B | 3.81B | 4.00B | 3.74B | 3.34B |
Cash Flow | |||||
| Free Cash Flow | 268.30M | 274.85M | 930.57M | 695.90M | 544.95M |
| Operating Cash Flow | 280.84M | 291.67M | 955.08M | 724.65M | 565.66M |
| Investing Cash Flow | 117.86M | 208.74M | -61.41M | -530.24M | -496.67M |
| Financing Cash Flow | -641.70M | -1.00B | -766.01M | -400.40M | -322.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$112.94B | 11.54 | 25.39% | 2.92% | 5.89% | 9.36% | |
75 Outperform | HK$17.60B | 6.11 | 15.06% | 4.43% | 4.91% | 4.61% | |
73 Outperform | HK$4.52B | 7.62 | 11.54% | 12.09% | -9.21% | -47.87% | |
71 Outperform | HK$14.92B | 12.63 | 11.18% | 2.78% | 6.95% | 28.21% | |
70 Outperform | HK$13.27B | 5.67 | 23.68% | 3.82% | 6.30% | -9.60% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
57 Neutral | HK$20.81B | -11.05 | 1.68% | 4.94% | 9.98% | -68.38% |